Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze AKRO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AKRO investment potential.

What is AKRO stock price today?

Get real-time AKRO stock price, historical data, and price charts on Financhill. Track AKRO performance with our advanced analysis tools.

Is AKRO a good investment?

Evaluate AKRO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy AKRO stock?

To buy AKRO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AKRO?

View detailed market capitalization data and company valuation metrics for AKRO on our comprehensive analysis page.

What is the P/E ratio of AKRO?

Use our fundamental analysis tools to view AKRO P/E ratio and compare valuation metrics with industry peers.

What are AKRO earnings?

View AKRO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Akero Therapeutics, Inc. Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

AKRO
Akero Therapeutics, Inc.

Last Price:

$54.65

Seasonality Move:

1.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

Akero Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Akero Therapeutics, Inc. has on average historically risen by 34.5% based on the past 6 years of stock performance.
Akero Therapeutics, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Akero Therapeutics, Inc. Stock Undervalued?

The current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Akero Therapeutics, Inc. has on average historically risen by 34.5% based on the past 6 years of stock performance.

Akero Therapeutics, Inc. Stock Rating

Buy

Akero Therapeutics, Inc. (AKRO) is a Buy

Is Akero Therapeutics, Inc. overpriced?

Akero Therapeutics, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Akero Therapeutics, Inc. Stock Price History

Is AKRO stock going to rise?

The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

akerotx.com/

52-Week Data

52-Week High:

58.40

52-Week Low:

21.34

Prediction Charts

Market Cap:

4.5B

Price in USD:

54.65

Volume:

Beta:

-0.03

Technical Analysis

SMA50:

54.21

SMA100:

50.58

SMA200:

48.49

52-Wk Change:

90.35%

Stock Predictions

Is Akero Therapeutics, Inc. stock public?

Yes, Akero Therapeutics, Inc. is a publicly traded company.
What is the Akero Therapeutics, Inc. stock quote today?

The Akero Therapeutics, Inc. stock price is 54.65 USD today.
How to buy Akero Therapeutics, Inc. stock online?

You can buy Akero Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-1	54.35	54.44	54.48	54.35
Dec-2	54.46	54.49	54.52	54.42
Dec-3	54.49	54.69	54.70	54.44
Dec-4	54.68	54.63	54.69	54.53
Dec-5	54.65	54.55	54.65	54.30
Dec-8	54.52	54.65	54.83	54.37
Dec-9	54.65	54.65	54.65	54.65
Dec-10	54.65	54.65	54.65	54.65
Dec-11	54.65	54.65	54.65	54.65
Dec-12	54.65	54.65	54.65	54.65
Dec-15	54.65	54.65	54.65	54.65
Dec-16	54.65	54.65	54.65	54.65
Dec-17	54.65	54.65	54.65	54.65
Dec-18	54.65	54.65	54.65	54.65

Akero Therapeutics, Inc. Earnings

Akero Therapeutics, Inc. Earnings Report: Per Share Akero Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics, Inc. Forecast Revenue Growth

Akero Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.32 per share.

* Akero Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.